Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review
Kevin Dzobo, Dimakatso Alice Senthebane, Chelene Ganz, et al.
Cells (2020) Vol. 9, Iss. 8, pp. 1896-1896
Open Access | Times Cited: 96

Showing 26-50 of 96 citing articles:

Circadian Clock Gene bmal1 Acts as a Tumor Suppressor Gene in a Mice Model of Human Glioblastoma
Laura Lucía Trebucq, Nicolas Salvatore, Paula M. Wagner, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 8, pp. 5216-5229
Closed Access | Times Cited: 4
Development and Validation of a Robust Pyroptosis-Related Signature for Predicting Prognosis and Immune Status in Patients with Colon Cancer
Zhicheng Zhuang, Huajun Cai, Hexin Lin, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-20
Open Access | Times Cited: 31
Tumor Microenvironment: A Niche for Cancer Stem Cell Immunotherapy
Mia C. Borlongan, Dipongkor Saha, Hongbin Wang
Stem Cell Reviews and Reports (2023) Vol. 20, Iss. 1, pp. 3-24
Closed Access | Times Cited: 14
Cancer Stem Cells and the Tumor Microenvironment in Tumor Drug Resistance
Qiuzhi Gao, Yixiang Zhan, Li Sun, et al.
Stem Cell Reviews and Reports (2023) Vol. 19, Iss. 7, pp. 2141-2154
Closed Access | Times Cited: 12
ThermomiR-377-3p-induced suppression of Cirbp expression is required for effective elimination of cancer cells and cancer stem-like cells by hyperthermia
Tao-Yan Lin, Jun-Shuang Jia, Weiren Luo, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 4
Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment
Zhiyun Cao, Nathaniel Weygant, Parthasarathy Chandrakesan, et al.
Cancers (2020) Vol. 12, Iss. 12, pp. 3801-3801
Open Access | Times Cited: 35
Targeted Therapies in Cancer: To Be or Not to Be, Selective
Skye Montoya, Deborah Soong, Nina Nguyen, et al.
Biomedicines (2021) Vol. 9, Iss. 11, pp. 1591-1591
Open Access | Times Cited: 29
Temozolomide Treatment Induces HMGB1 to Promote the Formation of Glioma Stem Cells via the TLR2/NEAT1/Wnt Pathway in Glioblastoma
Gao X, Jian Zang, Min Zheng, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 28
CAR‐T therapy: Prospects in targeting cancer stem cells
Xiaoyue Cui, Rui Liu, Lian Duan, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 25, Iss. 21, pp. 9891-9904
Open Access | Times Cited: 28
Cancer Metastasis and Treatment Resistance: Mechanistic Insights and Therapeutic Targeting of Cancer Stem Cells and the Tumor Microenvironment
Ethan J. Kilmister, Sabrina P. Koh, Freya R. Weth, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2988-2988
Open Access | Times Cited: 18
Development of new LSM-83177 analogues as anti-tumor agents against colorectal cancer targeting p53-MDM2 interaction
Mohamed K. Elgohary, Mahmoud S. Elkotamy, Tarfah Al‐Warhi, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107766-107766
Closed Access | Times Cited: 3
Cancer Stem Cell (CSC) Inhibitors in Oncology—A Promise for a Better Therapeutic Outcome: State of the Art and Future Perspectives
Prashant S. Kharkar
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 24, pp. 15279-15307
Closed Access | Times Cited: 31
Pleiotropic Actions of PGRMC Proteins in Cancer
James K. Pru
Endocrinology (2022) Vol. 163, Iss. 7
Open Access | Times Cited: 16
CXCR1: A Cancer Stem Cell Marker and Therapeutic Target in Solid Tumors
Caitlin Molczyk, Rakesh K. Singh
Biomedicines (2023) Vol. 11, Iss. 2, pp. 576-576
Open Access | Times Cited: 8
Bacterial Outer Membrane Vesicles Loaded with Perhexiline Suppress Tumor Development by Regulating Tumor-Associated Macrophages Repolarization in a Synergistic Way
Shoujin Jiang, Wei Fu, Sijia Wang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11222-11222
Open Access | Times Cited: 8
Nanocarrier-based targeting of metabolic pathways for endometrial cancer: Status and future perspectives
Yichao Wang, Siyao Chen, Hong Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115348-115348
Open Access | Times Cited: 8
How the interplay among the tumor microenvironment and the gut microbiota influences the stemness of colorectal cancer cells
María Belén Novoa Díaz, Pedro Carriere, Claudia Gentili
World Journal of Stem Cells (2023) Vol. 15, Iss. 5, pp. 281-301
Open Access | Times Cited: 7
Physicochemical parameters that underlie inkjet printing for medical applications
Sina Azizi Machekposhti, Saeid Movahed, Roger J. Narayan
Biophysics Reviews (2020) Vol. 1, Iss. 1
Closed Access | Times Cited: 21
Personalized models of heterogeneous 3D epithelial tumor microenvironments: Ovarian cancer as a model
Eric N. Horst, Michael E. Bregenzer, Pooja Mehta, et al.
Acta Biomaterialia (2021) Vol. 132, pp. 401-420
Open Access | Times Cited: 17
Basic and translational research on carbon-ion radiobiology.
Sei Sai, Masashi Koto, Shigeru Yamada
PubMed (2023) Vol. 13, Iss. 1, pp. 1-24
Closed Access | Times Cited: 6
Eradicating the tumor “seeds”: nanomedicines-based therapies against cancer stem cells
Lin Li, Rui Ni, Dan Zheng, et al.
DARU Journal of Pharmaceutical Sciences (2023) Vol. 31, Iss. 1, pp. 83-94
Open Access | Times Cited: 6
MicroRNAs and colorectal cancer: clinical potential and regulatory networks
George Yiadom Osei, Joseph Adu‐Amankwaah, Selina Koomson, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 11, pp. 9575-9585
Closed Access | Times Cited: 6
The anti‑epithelial cell adhesion molecule (EpCAM) monoclonal antibody EpMab‑16 exerts antitumor activity in a mouse model of colorectal adenocarcinoma
Hideki Hosono, Tomokazu Ohishi, Junko Takei, et al.
Oncology Letters (2020) Vol. 20, Iss. 6, pp. 1-1
Open Access | Times Cited: 19
CD44 expressed by myeloid cells promotes glioma invasion
Ekaterina L. Ivanova, Barbara Costa, Tanja Eisemann, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 11
Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia
Jie Wang, Hao Jian-ping, Md. Nazim Uddin, et al.
Aging (2021) Vol. 13, Iss. 12, pp. 16445-16470
Open Access | Times Cited: 15

Scroll to top